Medical Coding Automation: Where Clinical Review Adds Value
Health systems are investing in medical coding automation to reduce administrative burden, improve coding accuracy, and support more efficient billing and reimbursement. Autonomous medical coding, AI clinical documentation, and automated coding review can each create operational value when matched to the appropriate use case.
But for a Chief Financial Officer (CFO), revenue cycle leader, or Clinical Documentation Integrity (CDI) executive, eliminating administrative strain is not the final measure of success. The more consequential question is what happens after the technology has completed its review. Can I trust it completely?
How many findings are clinically supported? How much internal work is required to validate them? Can the review identify opportunities beyond its original alert? And when a payer challenges the claim, can the recommendation be defended?
What Is Medical Coding Automation?
Those questions determine whether medical coding automation becomes a productivity tool, a source of additional work, or part of a complete pre-bill strategy.
Medical coding automation uses software to perform tasks within the coding workflow, such as assigning codes, checking coding relationships, and identifying potential documentation or coding issues. Its capabilities depend on the technology, available data, care setting, and configured scope.
Several related technologies support different parts of that workflow:
- Autonomous medical coding assigns codes without manual intervention for encounters that meet the system’s defined requirements. Cases outside those requirements may still need human review.
- AI clinical documentation helps clinicians create or organize documentation, including draft clinical notes. Those notes still require clinician review and may become inputs for downstream coding.
- Automated coding review evaluates existing documentation and coding to flag potential discrepancies, sequencing issues, or DRG opportunities for further assessment.
For health systems evaluating inpatient pre-bill review, understanding these differences helps clarify what a solution produces, who validates its output, and how recommendations enter the billing workflow.
The Question Is No Longer Whether Automation Works
Medical coding automation can process large volumes, apply repeatable logic, and surface potential documentation, coding, sequencing, and diagnosis-related group (DRG) opportunities. In routine, well-documented cases, that scale can improve speed and consistency.
However, analyzing more charts does not automatically mean identifying every supported opportunity—or converting every alert into a measurable financial impact. The performance of a pre-bill program depends on both what the technology can detect and what the operating model does with the result.
| Buyer Goal | What Technology Can Deliver | What Still Requires Proof |
| Broad coverage | More charts analyzed | Whether high-value opportunities are found across the complete record |
| Better use of reviewer capacity | Greater potential review volume | How many alerts are accurate, actionable, and worth the internal effort |
| Faster processing | Improved throughput | Whether speed is maintained without weakening clinical support or compliance |
| Revenue identification | Potential financial opportunity | Whether the recommendation is accepted, realized, and defensible under payer review |
What Happened After an AI Solution Had Already Reviewed the Charts?
In a 2026 internal analysis, Enjoin reviewed the same 51 inpatient encounters after an existing AI solution had completed its review. The technology identified approximately $78,000 in revenue opportunity. Enjoin’s subsequent review identified approximately $553,000 across those encounters—about seven times the revenue opportunity identified by the technology alone. [8]
| Comparison | Result |
| Encounters reviewed | 51 inpatient encounters |
| Revenue opportunity identified by existing AI solution | $78,000 |
| Revenue opportunity identified through Enjoin review | $553,000 |
| Relative result | Approximately 7 times the identified revenue opportunity |
The comparison illustrates an important consideration for health-system buyers: comprehensive expert review may identify opportunities beyond those identified by an automated first pass.
The analysis involved a defined 51-encounter cohort and should not be treated as a guaranteed result for every organization. Outcomes depend on patient population, payer mix, technology configuration, review scope, existing workflows, and the underlying documentation.[8]
Why Opportunity Can Remain After Automated Review
1. Technology evaluates what it was designed to evaluate
Every platform has boundaries. A system may be highly effective within its configured pathways while still missing findings outside the original alert, focus list, data source, or modeled relationship. The issue is not necessarily that the technology is wrong; it may simply stop where its designed logic stops.
2. An automated finding is not the complete patient story.
The FY 2026 ICD-10-CM Official Guidelines state that code assignment is based on provider documentation and emphasize collaboration between the provider and the coder. AHIMA’s clinical validation guidance similarly distinguishes a documented diagnosis from whether the record contains sufficient clinical support for that diagnosis. [1, 2]
For competing principal diagnoses, questionable support for complications or comorbidities (CCs) and major complications or comorbidities (MCCst, conflicting documentation, or DRGs under active payer scrutiny, the reviewer may need to interpret the entire encounter rather than an isolated code, note, laboratory value, or alert.
3. An alert still has an operational cost
A low-confidence finding is not free simply because software generated it. CDI specialists, coders, physicians, and revenue cycle teams may still need to investigate the record, determine whether clarification is appropriate, reconcile conflicting information, and document why the recommendation should—or should not—move forward.
A health system should evaluate not only alert volume, but also the human effort required to convert those alerts into accurate action.
4. Defensibility matters after the claim is submitted
MDaudit’s 2024 Annual Benchmark Report found that coding-related denials increased 126% in 2024. CMS states that Recovery Audit Contractors perform automated and complex post-payment reviews, with qualified reviewers examining medical records during complex reviews. The HHS Office of Inspector General also continues hospital compliance reviews focused on selected Medicare billing requirements. [3, 4, 5]
In that environment, the value of a recommendation is not limited to the payment it may create. Health systems also need to understand whether documentation, coding logic, and clinical rationale can withstand scrutiny.
Where Physician Validation Changes the Decision
Not every chart needs a physician. Physician validation is most valuable when the decision depends on clinical interpretation rather than code logic alone. Common escalation scenarios include:
- Competing principal diagnoses where the condition chiefly responsible for admission is not immediately clear
- High-impact secondary diagnoses that may change severity or reimbursement but require stronger clinical support
- Conflicting, incomplete, or ambiguous documentation that may warrant clarification
- Cases in which a technically possible query may not be clinically appropriate
- DRG assignments that are likely to receive heightened payer scrutiny
The objective is not to maximize the number of recommendations. It is to determine which findings are clinically supported, compliant, actionable, and worth advancing.
How Enjoin Extends the Value of Medical Coding Automation
EnFORM+ is Enjoin’s proprietary clinical intelligence and prioritization technology. It analyzes 100% of eligible inpatient discharges within the agreed engagement scope, applies deterministic clinical and DRG logic, and prioritizes potential opportunities for deeper review.[6]
The technology does not make the final clinical determination. Clinical coding analysts examine the complete patient record and evaluate findings beyond the initial flagged opportunity. Cases are routed or escalated for physician validation when appropriate. The health system receives a supported recommendation it can evaluate through its established coding and query processes.[6]
| Stage | What Happens | Primary Role |
| Analyze | Screen 100% of eligible inpatient discharges within the agreed scope | EnFORM+ |
| Prioritize | Rank potential documentation, coding, sequencing, and DRG opportunities | EnFORM+ and clinical operations |
| Review | Evaluate the complete patient record, including findings beyond the initial signal | Clinical coding analysts |
| Validate | Assess complex or high-risk findings for clinical support and defensibility | Physician advisors, as appropriate |
| Recommend | Return a documented finding for the health system’s established workflow | Enjoin review team and client team |
| Improve | Use patterns to inform education, denial prevention, and performance improvement | Clinical, coding, education, and client teams |
Enjoin reports more than $3 billion in revenue recovery, a 900%+ average return on investment, and a denial rate below 2% on reviewed cases.[7] These are Enjoin-reported outcomes and may vary by organization, program design, population, payer mix, and implementation.
Five Questions to Ask Before Expanding Medical Coding Automation
1. Does the solution evaluate the complete patient record—or only the original alert?
Ask which clinical, coding, financial, laboratory, medication, order, imaging, and pathology data are available for the review. Then ask whether reviewers can identify findings outside the condition or pathway that caused the chart to be surfaced.
2. Who is accountable for clinical validation?
Determine which findings move forward automatically, which are reviewed by coding or CDI professionals, and when physician expertise enters the workflow. The answer should be specific enough to understand both risk and staffing impact.
3. How much work does each finding create for your internal team?
Alert volume is not the same as productivity. Measure how many recommendations require investigation, how often findings are accepted, and how much internal time is required before the claim can proceed.
4. How are recommendations linked to financial outcomes?
Ask whether reporting distinguishes identified opportunities, accepted recommendations, billing changes, and realized reimbursement. Understand how each measure is calculated and whether the partner can track recommendations through the health system’s billing workflow.
5. What happens if a reviewed claim is denied?
Understand whether the partner supports denial analysis and appeals, whether that support is included or separately priced, and whether pre-bill findings feed a learning loop for future prevention.
Measure the Outcome, Not Just the Output
Medical coding automation should be evaluated by more than the number of charts processed or alerts produced. Health-system leaders should also examine recommendation acceptance, billing changes, realized reimbursement, internal labor required per finding, turnaround time, denial performance on reviewed cases, and whether findings translate into sustained documentation and coding improvement.
The conclusion from Enjoin’s 51-encounter comparison is not that technology should be removed from the workflow. It is that technology is often the first pass. The larger opportunity comes from combining population-scale analysis with complete-record review, clinical coding expertise, and physician judgment where it materially changes the decision.
See how Enjoin combines technology and physician expertise to uncover more clinically supported value before billing.
Last updated: August 6, 2026
Sources
- [1] Centers for Disease Control and Prevention, National Center for Health Statistics. FY 2026 ICD-10-CM Official Guidelines for Coding and Reporting. https://stacks.cdc.gov/view/cdc/250974/cdc_250974_DS1.pdf
- [2] American Health Information Management Association. Clinical Validation Practice Brief. https://www.ahima.org/landing-pages/clinical-validation-practice-brief/
- [3] MDaudit. 2024 Annual Benchmark Report. https://meetings.hayesmanagement.com/hubfs/MDaudit%202024%20Benchmark%20Report.pdf
- [4] Centers for Medicare & Medicaid Services. Medicare Fee-for-Service Recovery Audit Program. https://www.cms.gov/data-research/monitoring-programs/medicare-fee-service-compliance-programs/medicare-fee-service-recovery-audit-program
- [5] U.S. Department of Health and Human Services, Office of Inspector General. Selected Inpatient and Outpatient Billing Requirements. https://oig.hhs.gov/reports/work-plan/browse-work-plan-projects/srs-a-25-012/
- [6] Enjoin. How EnFORM+ Works: A Guide to Implementation, Scalability, and Defensible Revenue Impact. https://www.enjoincdi.com/blog/how-enform-works/
- [7] Enjoin. CDI Best Practices: What Separates High-Performing Programs. https://www.enjoincdi.com/blog/cdi-best-practices/
- [8] Enjoin internal case analysis. Comparison of 51 inpatient encounters reviewed after an existing AI solution, 2026. Internal analysis; results may not be representative of every engagement.